口腔鳞状细胞癌患者的miRNAs表达:两种假定生物标志物的验证
miRNAs expression of oral squamous cell carcinoma patients: Validation of two putative biomarkers.
作者信息
Chamorro Petronacci Cintia Micaela, Pérez-Sayáns Mario, Padín Iruegas María Elena, Suárez Peñaranda José M, Lorenzo Pouso Alejandro Ismael, Blanco Carrión Andrés, García García Abel
机构信息
Oral Medicine, Oral Surgery and Implantology Unit, Faculty of Medicine and Dentistry, Santiago de Compostela University, Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela.
Human Anatomy and Embryology Area, Faculty of Physiotherapy, Department of Functional Biology and Health Sciences, Pontevedra, Vigo University.
出版信息
Medicine (Baltimore). 2019 Mar;98(13):e14922. doi: 10.1097/MD.0000000000014922.
microRNA expression patterns have provided new directions in the search of biomarkers with prognostic value and even in the search of novel therapeutic targets for several neoplasms. Specifically, miRNAs profiling in oral squamous cell carcinoma (OSCC) represents a web of intrigue in the study of oral carcinogenesis. The objective of the present study was twofold:The first study phase comprised case-control groups: A) 8 OSCC-affected patients and 8 healthy controls. Microarray technology (Affymetrix miRNA Array Plate 4.1) was used for miRNAs expression profile. Deregulated miRNAs were studied using Diana Tools miRPath 3.0 to associate miRNA targets with molecular pathways via Kyoto Encyclopedia of Genes and Genomes (KEGG). In a second phase, 2 miRNAs chosen for the subsequent RT-qPCR validation were studied in a second OSSC cohort (n = 8).Microarray analysis identified 80 deregulated miRNAs (35 over-expressed and 45 under-expressed). Two miRNAs (miR-497-5p and miR-4417) were chosen for further validation via RT-qPCR. Prognostic analysis did not ascertain relevant relation between miR-497-5p or miR-4417 expression and clinical or pathological parameters, except high miR-4417 in the case of nodular affectation (P = .035) and diminished miR-497-5p radiotherapy-treated patients (P = .05). KEGG analysis revealed that deregulated miRNAs were implicated in several biological pathways such as Proteoglycans in cancer.Our data suggest an altered miRNAs profiling in OSCC-affected patients. We have verified the altered expression of miR-497-5p and miR-4417 in OSCC samples and related the deregulated miRNAs with the 'proteoglycans in cancer' pathway. Further longitudinal studies with large samples are warranted to confirm the present findings.
微小RNA表达模式为寻找具有预后价值的生物标志物乃至为几种肿瘤寻找新的治疗靶点提供了新方向。具体而言,口腔鳞状细胞癌(OSCC)中的微小RNA谱在口腔癌发生研究中代表了一个充满谜团的网络。本研究的目的有两个:第一个研究阶段包括病例对照组:A)8名受OSCC影响的患者和8名健康对照。使用微阵列技术(Affymetrix miRNA Array Plate 4.1)进行微小RNA表达谱分析。使用Diana Tools miRPath 3.0研究失调的微小RNA,以通过京都基因与基因组百科全书(KEGG)将微小RNA靶标与分子途径相关联。在第二阶段,在第二个OSCC队列(n = 8)中研究了选择用于后续RT-qPCR验证的2种微小RNA。微阵列分析鉴定出80种失调的微小RNA(35种过表达和45种低表达)。选择了两种微小RNA(miR-497-5p和miR-4417)通过RT-qPCR进行进一步验证。预后分析未确定miR-497-5p或miR-4417表达与临床或病理参数之间的相关关系,除了在结节性病变情况下miR-4417高表达(P = 0.035)以及接受放疗的患者中miR-497-5p降低(P = 0.05)。KEGG分析表明,失调的微小RNA涉及多种生物学途径,如癌症中的蛋白聚糖。我们的数据表明受OSCC影响的患者中微小RNA谱发生了改变。我们已经验证了OSCC样本中miR-497-5p和miR-4417的表达改变,并将失调的微小RNA与“癌症中的蛋白聚糖”途径相关联。需要进一步进行大样本的纵向研究以证实目前的发现。